UPPER RESPIRATORY DISEASE
Clinical trials for UPPER RESPIRATORY DISEASE explained in plain language.
Never miss a new study
Get alerted when new UPPER RESPIRATORY DISEASE trials appear
Sign up with your email to follow new studies for UPPER RESPIRATORY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which COVID-19 booster works better? new study pits novavax against pfizer
⭐️ VACCINE ⭐️ CompletedThis study tested how well two updated COVID-19 vaccines (Novavax and Pfizer mRNA) protect adults from getting sick. About 1,188 people who had already received at least two mRNA vaccine doses took part. Participants were randomly assigned to get either the Novavax or Pfizer vacc…
Matched conditions: UPPER RESPIRATORY DISEASE
Phase: PHASE4 • Sponsor: Sarang K. Yoon, DO, MOH • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 15:58 UTC
-
Could a cold virus drug shield COPD lungs?
Disease control CompletedThis study tested an experimental drug called vapendavir in 52 adults with COPD (a chronic lung disease). The goal was to see if the drug could reduce severe cold symptoms caused by rhinovirus, a common cold virus. Participants were given either vapendavir or a placebo and monito…
Matched conditions: UPPER RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 03:38 UTC